15-60351753-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_004039.3(ANXA2):c.749G>A(p.Gly250Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,613,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004039.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANXA2 | NM_004039.3 | c.749G>A | p.Gly250Glu | missense_variant | 10/13 | ENST00000451270.7 | NP_004030.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANXA2 | ENST00000451270.7 | c.749G>A | p.Gly250Glu | missense_variant | 10/13 | 1 | NM_004039.3 | ENSP00000387545.3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251464Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135908
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461296Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727006
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.803G>A (p.G268E) alteration is located in exon 10 (coding exon 10) of the ANXA2 gene. This alteration results from a G to A substitution at nucleotide position 803, causing the glycine (G) at amino acid position 268 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at